Coronavirus (COVID-19) - Latest Information for Patients and Visitors

(La más reciente información para pacientes y visitantes)


Read Now (Lea ahora)
800-TEMPLE-MED Schedule Appointment

Media Highlight New $2.5 Million NIDDK Grant That Gives Temple Researchers Opportunity to Advance Tools to Predict Hospital Readmission Among Patients with Diabetes

View All News

Daniel J. Rubin, MD, MSc, FACE, Associate Professor of Medicine at the Lewis Katz School of Medicine at Temple University and Chair of the Glycemic Control Taskforce at Temple University Hospital, is the lead investigator on a new five-year grant from the National Institute of Diabetes and Digestive and Kidney Diseases. The $2.5 million in funding will allow researchers to better predict which patients with diabetes are most likely to experience additional hospital visits by aiming to develop improved models that accurately and automatically predict 30-day readmission risk based on electronic health record data. Anuradha Paranjape, MD, MPH, FACP, Vice Chair of Clinical Affairs in the Department of Medicine and Professor of Medicine and Professor of Clinical Sciences at LKSOM, is a collaborator on the project. Media outlets, including, highlighted the new grant.